US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Palisade Bio Inc.

1.16

+0.05004.50%

Post-market: 1.12-0.0400-3.45%19:59 EDT

Volume:1.52M

Turnover:1.84M

Market Cap:5.56M

PE:-0.21

High:1.29

Open:1.13

Low:1.12

Close:1.11

Loading ...

Overview Company News Filings

Palisade Bio Inc. Announces $3.9 Million Private Placement Through Warrant Exercise

Palisade Bio Inc. Files Initial Statement of Beneficial Ownership for Director Emil Chuang

Palisade Bio appoints to its Board of Directors

Palisade Bio Inc. Appoints Emil Chuang to Board of Directors to Strengthen Clinical Strategy in Autoimmune and Inflammatory Diseases

Palisade Bio’s PALI-2108: Promising Phase 1 Results and Strategic Positioning Drive Buy Rating

Palisade Bio Is Maintained at Buy by Brookline Capital

Palisade Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Palisade Bio Q1 EPS $(0.47) Beats $(0.70) Estimate

Palisade Bio Inc expected to post a loss of 70 cents a share - Earnings Preview

Palisade Bio Inc. Receives Nasdaq Notice for Non-Compliance with Minimum Bid Price Requirement

Palisade completes dosing in Phase 1b portion of Phase 1a/1n study of PALI-2108

BRIEF-Palisade Bio Completes Dosing In Phase 1A Portion Of Ongoing Phase 1A/B Study Of Pali-2108

Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108

U.S. RESEARCH ROUNDUP-Ashland, Connectone Bancorp, Neurocrine Biosciences

Palisade Bio Inc expected to post a loss of $1.99 a share - Earnings Preview

Palisade Bio Begins Dosing Ulcerative Colitis Patients in PALI-2108 Trial

MT Newswires Live

Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108

Palisade Bio Participates in Virtual Investor “What This Means” Segment

Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis

Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PALI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PALI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PALI\",,,,,undefined,":{"symbol":"PALI","market":"US","secType":"STK","nameCN":"Palisade Bio Inc.","latestPrice":1.16,"timestamp":1753473600000,"preClose":1.11,"halted":0,"volume":1523159,"hourTrading":{"tag":"盘后","latestPrice":1.12,"preClose":1.16,"latestTime":"19:59 EDT","volume":30769,"amount":34728.5203,"timestamp":1753487987639},"delay":0,"floatShares":4301782,"shares":4795646,"eps":-5.422663,"marketStatus":"Closed","change":0.05,"latestTime":"07-25 16:00:00 EDT","open":1.13,"high":1.29,"low":1.1201,"amount":1838833.70275,"amplitude":0.153063,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-5.422663,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753689600000},"marketStatusCode":5,"adr":0,"listingDate":1188187200000,"exchange":"NASDAQ","adjPreClose":1.11,"preHourTrading":{"tag":"盘前","latestPrice":1.14,"preClose":1.11,"latestTime":"09:26 EDT","volume":17696,"amount":19984.3635488,"timestamp":1753450011526},"postHourTrading":{"tag":"盘后","latestPrice":1.12,"preClose":1.16,"latestTime":"19:59 EDT","volume":30769,"amount":34728.5203,"timestamp":1753487987639},"volumeRatio":0.494256},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PALI\",,,,,undefined,":{"symbol":"PALI","floatShares":4301782,"roa":"-80.94%","roe":"-170.72%","lyrEps":-10.192937,"volumeRatio":0.494256,"shares":4795646,"dividePrice":0,"high":1.29,"amplitude":0.153063,"preClose":1.11,"low":1.1201,"week52Low":0.6,"pbRate":"1.04","week52High":4.65,"institutionHeld":0.0656,"latestPrice":1.16,"eps":-5.422663,"divideRate":0,"volume":1523159,"delay":0,"ttmEps":-5.422663,"open":1.13,"prevYearClose":1.65,"prevWeekClose":0.7502,"prevMonthClose":0.6801,"prevQuarterClose":0.6801,"fiveDayClose":0.7502,"twentyDayClose":0.7138,"sixtyDayClose":0.7556},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PALI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554654027","title":"Palisade Bio Inc. Announces $3.9 Million Private Placement Through Warrant Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2554654027","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554654027?lang=en_us&edition=fundamental","pubTime":"2025-07-25 18:01","pubTimestamp":1753437703,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc. , a clinical-stage biopharmaceutical company, has announced an agreement with several accredited investors to exercise existing warrants to purchase up to 4,318,905 shares of common stock. These warrants have been exercised at a reduced price of $0.9047 per share, resulting in expected gross proceeds of approximately $3.9 million. The proceeds will be used for working capital and general corporate purposes. In exchange for the immediate exercise of these warrants, investors will receive new unregistered warrants, allowing them to purchase an additional 8,637,810 shares of common stock at the same exercise price, with a term of five years. Ladenburg Thalmann & Co. Inc. served as the exclusive placement agent for this transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDLDGPJH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","PALI"],"gpt_icon":0},{"id":"2552134434","title":"Palisade Bio Inc. Files Initial Statement of Beneficial Ownership for Director Emil Chuang","url":"https://stock-news.laohu8.com/highlight/detail?id=2552134434","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552134434?lang=en_us&edition=fundamental","pubTime":"2025-07-18 05:17","pubTimestamp":1752787060,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing lists Emil Chuang as a beneficial owner, serving in the role of a Director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL3RTg29:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2550630783","title":"Palisade Bio appoints to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2550630783","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550630783?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:50","pubTimestamp":1752065422,"startTime":"0","endTime":"0","summary":"Palisade Bio (PALI) announced it has appointed Emil Chuang to its Board of Directors. Chuang is a pediatric gastroenterologist with nearly 25 years...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palisade-bio-appoints-to-its-board-of-directors-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palisade-bio-appoints-to-its-board-of-directors-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PALI","BK4007"],"gpt_icon":0},{"id":"2550637758","title":"Palisade Bio Inc. Appoints Emil Chuang to Board of Directors to Strengthen Clinical Strategy in Autoimmune and Inflammatory Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2550637758","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550637758?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:46","pubTimestamp":1752065168,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc. Appoints Emil Chuang to Board of Directors to Strengthen Clinical Strategy in Autoimmune and Inflammatory Diseases. Palisade Bio Inc., a clinical-stage biopharmaceutical company, has announced the appointment of Emil Chuang, MB BS FRACP, to its Board of Directors. Dr. Chuang brings nearly 25 years of pharmaceutical and clinical experience, with a focus on autoimmune, inflammatory, and fibrotic diseases. His expertise includes significant contributions to drug development programs targeting inflammatory bowel diseases. Dr. Chuang currently serves as the Chief Medical Officer at Intrinsic Medicine and leads Chuang Global Consulting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL4lL0d0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","PALI"],"gpt_icon":0},{"id":"2536347359","title":"Palisade Bio’s PALI-2108: Promising Phase 1 Results and Strategic Positioning Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2536347359","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536347359?lang=en_us&edition=fundamental","pubTime":"2025-05-17 03:25","pubTimestamp":1747423516,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Naz Rahman from Maxim Group reiterated a Buy rating on Palisade Bio (PALI – Research Report), with a price target o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/palisade-bios-pali-2108-promising-phase-1-results-and-strategic-positioning-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/palisade-bios-pali-2108-promising-phase-1-results-and-strategic-positioning-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PALI"],"gpt_icon":0},{"id":"2535083081","title":"Palisade Bio Is Maintained at Buy by Brookline Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2535083081","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535083081?lang=en_us&edition=fundamental","pubTime":"2025-05-14 02:34","pubTimestamp":1747161240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PALI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2025 14:34 ET (18:34 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRKL","PALI"],"gpt_icon":0},{"id":"2535706701","title":"Palisade Bio Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535706701","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535706701?lang=en_us&edition=fundamental","pubTime":"2025-05-13 23:43","pubTimestamp":1747151022,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc reports results for the quarter ended March 31 - Earnings SummaryPalisade Bio Inc PALI.OQ reported a quarterly adjusted loss of 47 cents per share for the quarter ended March 31, high","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL8N3RL25R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI"],"gpt_icon":0},{"id":"2535780752","title":"Palisade Bio Q1 EPS $(0.47) Beats $(0.70) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535780752","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535780752?lang=en_us&edition=fundamental","pubTime":"2025-05-13 05:34","pubTimestamp":1747085658,"startTime":"0","endTime":"0","summary":"Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.70) by 32.86 percent. This is a 89.76 percent increase over losses of $(4.59) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45362786/palisade-bio-q1-eps-0-47-beats-0-70-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI"],"gpt_icon":0},{"id":"2534343115","title":"Palisade Bio Inc  expected to post a loss of 70 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534343115","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534343115?lang=en_us&edition=fundamental","pubTime":"2025-05-09 23:16","pubTimestamp":1746803780,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc  expected to post a loss of70cents a share - Earnings Preview Palisade Bio Inc PALI.OQ PALI.O is expected to show no change in quarterly revenue when it reports  results on May 12 (es","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH2FL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI"],"gpt_icon":0},{"id":"2532043872","title":"Palisade Bio Inc. Receives Nasdaq Notice for Non-Compliance with Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2532043872","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532043872?lang=en_us&edition=fundamental","pubTime":"2025-05-03 04:13","pubTimestamp":1746216824,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc. has announced that it received a notice from The Nasdaq Stock Market LLC regarding non-compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company's common stock has closed below the $1.00 per share minimum for 30 consecutive trading days. Currently, the listing of Palisade Bio's common stock remains unaffected, and it continues to trade under the symbol \"PALI.\" The company now has 180 calendar days to regain compliance by achieving a closing bid price of at least $1.00 for a minimum of 10 consecutive business days. If necessary, an additional 180-day period may be granted, provided other listing standards are met. Palisade Bio is monitoring the situation and may explore options to address the deficiency.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nNDL6LCwV8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"2526366631","title":"Palisade completes dosing in Phase 1b portion of Phase 1a/1n study of PALI-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2526366631","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526366631?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:36","pubTimestamp":1744202180,"startTime":"0","endTime":"0","summary":"Palisade Bio (PALI) announced the completion of enrollment and dosing in all five Phase 1a SAD cohorts, all four MAD cohorts, and the food effects ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palisade-completes-dosing-in-phase-1b-portion-of-phase-1a-1n-study-of-pali-2108?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palisade-completes-dosing-in-phase-1b-portion-of-phase-1a-1n-study-of-pali-2108?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"2526736500","title":"BRIEF-Palisade Bio Completes Dosing In Phase 1A Portion Of Ongoing Phase 1A/B Study Of Pali-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2526736500","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526736500?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:35","pubTimestamp":1744202143,"startTime":"0","endTime":"0","summary":"BRIEF-Palisade Bio Completes Dosing In Phase 1A Portion Of Ongoing Phase 1A/B Study Of Pali-2108April 9 (Reuters) - Palisade Bio Inc PALI.O:PALISADE BIO COMPLETES DOSING IN PHASE 1A PORTION OF ONGOING","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN0W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"2526366885","title":"Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2526366885","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526366885?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:30","pubTimestamp":1744201800,"startTime":"0","endTime":"0","summary":"Sustained positive preliminary data from all completed single ascending dose (SAD) cohorts, multiple ascending dose (MAD) cohorts, and food effects crossover, further supporting the safety and tolerab","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/09/3058394/0/en/Palisade-Bio-Completes-Dosing-in-Phase-1a-Portion-of-Ongoing-Phase-1a-b-Study-of-PALI-2108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2265009873.SGD","BK4534","BK4007","BK4198","LU1804176565.USD","PALI","BK4139","ALC"],"gpt_icon":0},{"id":"2522617819","title":"U.S. RESEARCH ROUNDUP-Ashland, Connectone Bancorp, Neurocrine Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2522617819","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522617819?lang=en_us&edition=fundamental","pubTime":"2025-03-26 15:46","pubTimestamp":1742975171,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Ashland, Connectone Bancorp, Neurocrine Biosciences March 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL3N3Q90KA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","PALI","IE00B7SZLL34.SGD","CNOB","BK4139","LU0889565916.HKD","LU2229751404.USD","LU0053671581.USD","LU0266013472.USD","BK4200","IE00B19Z4B17.USD","BK4077","PZZA","LU0029874061.USD","LAKE","IE0031619046.USD","RUM","IE00B19Z3581.USD","BK4183","BK4539","BK4104","IE00B7SZL793.SGD","LU2089279066.USD","LU2125910336.SGD","ULTA","LU2087625088.SGD","BK4590","KBH","LU2065171402.SGD","FRPT","IE0002270589.USD","LU2125910179.SGD","CNM","LU2065170008.USD","BK4090","IE00B19Z3B42.SGD","LU0823411888.USD","LU0823416689.USD","LU2065171311.SGD","SUN","CRMD","BK4211","NBIX","COTY","WLK","ASH","CRNX","LU0353189680.USD","LU2463526074.USD","BK4516"],"gpt_icon":0},{"id":"2521289492","title":"Palisade Bio Inc  expected to post a loss of $1.99 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521289492","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521289492?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:03","pubTimestamp":1742562198,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc  expected to post a loss of $1.99 a share - Earnings Preview Palisade Bio Inc PALI.OQ PALI.O is expected to show no change in quarterly revenue when it reports  results on March 25 (e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q415K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI"],"gpt_icon":1},{"id":"2519730809","title":"Palisade Bio Begins Dosing Ulcerative Colitis Patients in PALI-2108 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2519730809","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519730809?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:57","pubTimestamp":1741957023,"startTime":"0","endTime":"0","summary":"Palisade Bio  said Friday it began dosing ulcerative colitis patients in the final cohort of its phase 1a/b study of PALI-2108.The company said it had completed five single ascending dose cohorts and three of four multiple ascending dose cohorts, with no serious adverse events or treatment-related adverse events tied to lab results or EKGs.Palisade Bio said it plans to report topline data in H1.Shares of the company were up 3% in recent Friday premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PALI","BK4007"],"gpt_icon":1},{"id":"2519061888","title":"Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2519061888","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519061888?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:30","pubTimestamp":1741955400,"startTime":"0","endTime":"0","summary":"Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts support safety and tolerability of PALI-2108 No serious adve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/14/3042967/0/en/Palisade-Bio-Commences-Dosing-in-First-Ulcerative-Colitis-Patient-Cohort-in-Ongoing-Phase-1a-b-Study-of-PALI-2108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALC","LU2265009873.SGD","BK4139","LU1804176565.USD","BK4534","BK4007","PALI","BK4198"],"gpt_icon":0},{"id":"2516679792","title":"Palisade Bio Participates in Virtual Investor “What This Means” Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2516679792","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516679792?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:30","pubTimestamp":1741095000,"startTime":"0","endTime":"0","summary":"Dr. Joerg Heyer, Head of Translational Science and Medicine of Palisade Bio highlights preclinical data for lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis . Carlsbad, CA, March 04, 2025  -- Palisade Bio, Inc.  , a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced the release of a Virtual Investor “What This Means” segment.As part of this segment, Dr. Heyer discussed the Company’s positive preclinical data for its lead product candidate, PALI-2108, which was recently presented at the 2025 Crohn’s and Colitis Congress and what this means for Palisade’s UC development program.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/palisade-bio-participates-virtual-investor-133000559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2510571238","title":"Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2510571238","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510571238?lang=en_us&edition=fundamental","pubTime":"2025-02-10 21:45","pubTimestamp":1739195100,"startTime":"0","endTime":"0","summary":"Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure  Company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/10/3023457/0/en/Palisade-Bio-Presents-Positive-Preclinical-Data-of-PALI-2108-for-the-Treatment-of-Ulcerative-Colitis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","BK4007","PALI","BK4139","PK","BK4218"],"gpt_icon":1},{"id":"2507636905","title":"Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2507636905","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507636905?lang=en_us&edition=fundamental","pubTime":"2025-01-29 21:45","pubTimestamp":1738158300,"startTime":"0","endTime":"0","summary":"Carlsbad,CA, Jan. 29, 2025  -- Palisade Bio, Inc. , a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that its abstract has been accepted for poster presentation at the Crohn’s & Colitis Congress being held February 6-8, 2025 in San Francisco, CA.Details of the poster presentation are as follows:. Session: Poster and Exhibition Hall ReceptionPoster Title: PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS Mouse Model Session Dates and Times: February 7, 2025 from 5:00 PM to 6:30 PM PSTPresentation Location: Level 1 – Exhibition Hall – Moscone West","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/palisade-bio-selected-poster-presentation-134500430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PALI","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PALI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"PALI","fiscalQuarterEnding":"2025/03","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2025-03-24","symbol":"PALI","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":-0.69},{"market":"US","date":"2024-11-12","symbol":"PALI","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-2.32},{"date":"2024-08-13","symbol":"PALI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723536000000,"name":null,"time":"Pre-Market","dateTimestamp":1723521600000,"actualEps":null},{"date":"2024-05-14","symbol":"PALI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715673600000,"name":null,"time":"Pre-Market","dateTimestamp":1715659200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PALI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PALI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1732161600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PALI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PALI","date":"2025-07-24","current":-0.445224,"percent":0.404528,"low":-8.398968,"twenty":-0.8231,"median":-0.396172,"eighty":-0.25143,"high":5.714804,"avg":-0.445121,"sd":1.279686,"marketCap":5850688},"quantilePoints":[{"date":"2021-04-30","current":-6.235722,"twenty":-7.595945,"median":-6.39141,"eighty":-6.297997,"marketCap":55734879},{"date":"2021-05-07","current":-4.877259,"twenty":-6.329135,"median":-5.199166,"eighty":-4.928997,"marketCap":43592940},{"date":"2021-05-14","current":-3.071774,"twenty":-5.894847,"median":-4.877259,"eighty":-4.31519,"marketCap":27455520},{"date":"2021-05-21","current":-3.088114,"twenty":-5.23604,"median":-4.366658,"eighty":-3.120792,"marketCap":27601560},{"date":"2021-05-28","current":-3.112623,"twenty":-5.01152,"median":-3.758022,"eighty":-3.016221,"marketCap":27820620},{"date":"2021-06-04","current":-3.088114,"twenty":-4.980735,"median":-3.235167,"eighty":-3.058703,"marketCap":27601560},{"date":"2021-06-11","current":-3.357711,"twenty":-4.834777,"median":-3.235167,"eighty":-3.075042,"marketCap":30011220},{"date":"2021-06-18","current":-3.37405,"twenty":-4.607662,"median":-3.316863,"eighty":-3.088114,"marketCap":30157260},{"date":"2021-06-25","current":-3.58646,"twenty":-4.374011,"median":-3.345457,"eighty":-3.091382,"marketCap":32055780},{"date":"2021-07-02","current":-2.965569,"twenty":-4.341333,"median":-3.341372,"eighty":-3.091382,"marketCap":26506260},{"date":"2021-07-09","current":-3.096283,"twenty":-4.289047,"median":-3.316863,"eighty":-3.071774,"marketCap":27674580},{"date":"2021-07-16","current":-2.056128,"twenty":-3.758022,"median":-3.239251,"eighty":-2.990078,"marketCap":24607740},{"date":"2021-07-23","current":-2.074432,"twenty":-3.59463,"median":-3.210658,"eighty":-2.883873,"marketCap":24826800},{"date":"2021-07-30","current":-1.787672,"twenty":-3.58646,"median":-3.198403,"eighty":-2.373394,"marketCap":21394860},{"date":"2021-08-06","current":-1.647343,"twenty":-3.553782,"median":-3.112623,"eighty":-2.123242,"marketCap":19715400},{"date":"2021-08-13","current":-1.58633,"twenty":-3.463916,"median":-3.092199,"eighty":-2.074432,"marketCap":18985200},{"date":"2021-08-20","current":-1.549723,"twenty":-3.447577,"median":-3.071774,"eighty":-1.928001,"marketCap":18547080},{"date":"2021-08-27","current":-0.68888,"twenty":-3.431237,"median":-2.990078,"eighty":-1.683951,"marketCap":28838584},{"date":"2021-09-03","current":-0.743337,"twenty":-3.431237,"median":-2.965569,"eighty":-1.659545,"marketCap":31118314},{"date":"2021-09-10","current":-0.816854,"twenty":-3.392023,"median":-2.932891,"eighty":-1.582669,"marketCap":34195950},{"date":"2021-09-17","current":-0.74606,"twenty":-3.375684,"median":-2.859364,"eighty":-1.503353,"marketCap":31232301},{"date":"2021-09-24","current":-0.658929,"twenty":-3.360979,"median":-2.373394,"eighty":-0.786902,"marketCap":27584733},{"date":"2021-10-01","current":-0.677989,"twenty":-3.351175,"median":-2.205609,"eighty":-0.760763,"marketCap":28382638},{"date":"2021-10-08","current":-0.756712,"twenty":-3.343006,"median":-2.123242,"eighty":-0.751505,"marketCap":31678255},{"date":"2021-10-15","current":-0.85246,"twenty":-3.3283,"median":-2.086634,"eighty":-0.753683,"marketCap":35686524},{"date":"2021-10-22","current":-0.80613,"twenty":-3.318497,"median":-2.056128,"eighty":-0.756215,"marketCap":33747039},{"date":"2021-10-29","current":-0.846283,"twenty":-3.303792,"median":-1.860887,"eighty":-0.76126,"marketCap":35427926},{"date":"2021-11-05","current":-0.880257,"twenty":-3.254774,"median":-1.683951,"eighty":-0.762791,"marketCap":36850215},{"date":"2021-11-12","current":-1.134957,"twenty":-3.236801,"median":-1.674799,"eighty":-0.764674,"marketCap":36242580},{"date":"2021-11-19","current":-1.045691,"twenty":-3.235167,"median":-1.659545,"eighty":-0.782546,"marketCap":33392040},{"date":"2021-11-26","current":-0.981929,"twenty":-3.220462,"median":-1.604634,"eighty":-0.786902,"marketCap":31355940},{"date":"2021-12-03","current":-0.786393,"twenty":-3.210658,"median":-1.558874,"eighty":-0.786902,"marketCap":25111900},{"date":"2021-12-10","current":-0.892663,"twenty":-3.210658,"median":-1.507014,"eighty":-0.786902,"marketCap":28505400},{"date":"2021-12-17","current":-0.807647,"twenty":-3.195953,"median":-1.139207,"eighty":-0.786902,"marketCap":25790600},{"date":"2021-12-23","current":-0.709879,"twenty":-3.179613,"median":-1.06907,"eighty":-0.786393,"marketCap":22668580},{"date":"2021-12-31","current":-0.552601,"twenty":-3.146935,"median":-0.994681,"eighty":-0.758986,"marketCap":17646200},{"date":"2022-01-07","current":-0.565353,"twenty":-3.109355,"median":-0.984055,"eighty":-0.751505,"marketCap":18053420},{"date":"2022-01-14","current":-0.552601,"twenty":-3.101185,"median":-0.973427,"eighty":-0.743337,"marketCap":17646200},{"date":"2022-01-21","current":-0.448457,"twenty":-3.094649,"median":-0.914232,"eighty":-0.729723,"marketCap":14320570},{"date":"2022-01-28","current":-0.467585,"twenty":-3.088114,"median":-0.892637,"eighty":-0.708328,"marketCap":14931400},{"date":"2022-02-04","current":-0.393367,"twenty":-3.084846,"median":-0.884161,"eighty":-0.689425,"marketCap":12561379},{"date":"2022-02-11","current":-0.429328,"twenty":-3.068506,"median":-0.872535,"eighty":-0.671031,"marketCap":13709740},{"date":"2022-02-18","current":-0.403016,"twenty":-3.042364,"median":-0.855548,"eighty":-0.659474,"marketCap":12869509},{"date":"2022-02-25","current":-0.391071,"twenty":-2.990078,"median":-0.850155,"eighty":-0.641867,"marketCap":12488080},{"date":"2022-03-04","current":-0.393154,"twenty":-2.990078,"median":-0.849371,"eighty":-0.599359,"marketCap":12554592},{"date":"2022-03-11","current":-0.442081,"twenty":-2.990078,"median":-0.849371,"eighty":-0.582356,"marketCap":14116960},{"date":"2022-03-18","current":-0.602849,"twenty":-2.965569,"median":-0.844549,"eighty":-0.565353,"marketCap":16045436},{"date":"2022-03-25","current":-0.801515,"twenty":-2.965569,"median":-0.837017,"eighty":-0.565353,"marketCap":21333136},{"date":"2022-04-01","current":-0.712458,"twenty":-2.932891,"median":-0.829295,"eighty":-0.573855,"marketCap":18962788},{"date":"2022-04-08","current":-0.650735,"twenty":-2.883873,"median":-0.816854,"eighty":-0.582356,"marketCap":17319954},{"date":"2022-04-14","current":-0.637102,"twenty":-2.870802,"median":-0.811898,"eighty":-0.585757,"marketCap":16957108},{"date":"2022-04-22","current":-0.615317,"twenty":-2.854463,"median":-0.806889,"eighty":-0.593409,"marketCap":16377284},{"date":"2022-04-29","current":-0.534344,"twenty":-2.831588,"median":-0.794895,"eighty":-0.573762,"marketCap":14222091},{"date":"2022-05-06","current":-0.422789,"twenty":-2.464052,"median":-0.788264,"eighty":-0.559402,"marketCap":11252961},{"date":"2022-05-13","current":-0.412841,"twenty":-2.329465,"median":-0.786902,"eighty":-0.547771,"marketCap":11060415},{"date":"2022-05-20","current":-0.424683,"twenty":-2.235505,"median":-0.786393,"eighty":-0.513494,"marketCap":11377678},{"date":"2022-05-27","current":-0.418149,"twenty":-2.200118,"median":-0.76512,"eighty":-0.503186,"marketCap":11202636},{"date":"2022-06-03","current":-0.444937,"twenty":-2.152528,"median":-0.762397,"eighty":-0.476087,"marketCap":11920305},{"date":"2022-06-10","current":-0.438567,"twenty":-2.123242,"median":-0.758562,"eighty":-0.466914,"marketCap":11749640},{"date":"2022-06-17","current":-0.367514,"twenty":-2.11226,"median":-0.754228,"eighty":-0.451634,"marketCap":9846067},{"date":"2022-06-24","current":-0.366126,"twenty":-2.102498,"median":-0.751505,"eighty":-0.445495,"marketCap":9808871},{"date":"2022-07-01","current":-0.325781,"twenty":-2.089075,"median":-0.746385,"eighty":-0.44007,"marketCap":8727991},{"date":"2022-07-08","current":-0.400264,"twenty":-2.071991,"median":-0.743612,"eighty":-0.43499,"marketCap":10723461},{"date":"2022-07-15","current":-0.383848,"twenty":-2.061009,"median":-0.737891,"eighty":-0.428094,"marketCap":10283670},{"date":"2022-07-22","current":-0.363839,"twenty":-2.043925,"median":-0.728361,"eighty":-0.424683,"marketCap":9747606},{"date":"2022-07-29","current":-0.315572,"twenty":-1.981692,"median":-0.721554,"eighty":-0.420835,"marketCap":8454489},{"date":"2022-08-05","current":-0.423458,"twenty":-1.901155,"median":-0.712458,"eighty":-0.418084,"marketCap":11344857},{"date":"2022-08-12","current":-0.570101,"twenty":-1.792553,"median":-0.709879,"eighty":-0.416508,"marketCap":15273575},{"date":"2022-08-19","current":4.414871,"twenty":-1.766928,"median":-0.701936,"eighty":-0.411475,"marketCap":11527227},{"date":"2022-08-26","current":4.512979,"twenty":-1.683951,"median":-0.68888,"eighty":-0.405749,"marketCap":11783387},{"date":"2022-09-02","current":4.029939,"twenty":-1.682731,"median":-0.683343,"eighty":-0.400558,"marketCap":10522170},{"date":"2022-09-09","current":4.038124,"twenty":-1.677849,"median":-0.676931,"eighty":-0.398303,"marketCap":10543542},{"date":"2022-09-16","current":3.819847,"twenty":-1.671748,"median":-0.667097,"eighty":-0.394592,"marketCap":9973621},{"date":"2022-09-23","current":3.113175,"twenty":-1.671748,"median":-0.660291,"eighty":-0.391921,"marketCap":8128501},{"date":"2022-09-30","current":2.701177,"twenty":-1.659545,"median":-0.650735,"eighty":-0.39079,"marketCap":7052774},{"date":"2022-10-07","current":2.709363,"twenty":-1.647343,"median":-0.642122,"eighty":-0.38563,"marketCap":7074146},{"date":"2022-10-14","current":2.589311,"twenty":-1.604634,"median":-0.637102,"eighty":-0.373068,"marketCap":6760690},{"date":"2022-10-21","current":2.837601,"twenty":-1.58633,"median":-0.630286,"eighty":-0.367514,"marketCap":7408975},{"date":"2022-10-28","current":2.589311,"twenty":-1.568026,"median":-0.61381,"eighty":-0.365524,"marketCap":6760690},{"date":"2022-11-04","current":2.335563,"twenty":-1.549723,"median":-0.605735,"eighty":-0.361316,"marketCap":6098156},{"date":"2022-11-11","current":2.23461,"twenty":-1.53752,"median":-0.602301,"eighty":-0.35118,"marketCap":5834568},{"date":"2022-11-18","current":-0.398957,"twenty":-1.507014,"median":-0.597644,"eighty":-0.35538,"marketCap":3776927},{"date":"2022-11-25","current":-0.610649,"twenty":-1.492371,"median":-0.60083,"eighty":-0.357408,"marketCap":5781011},{"date":"2022-12-02","current":-0.69044,"twenty":-1.212508,"median":-0.602849,"eighty":-0.359061,"marketCap":6536396},{"date":"2022-12-09","current":-0.498289,"twenty":-1.136657,"median":-0.60083,"eighty":-0.35977,"marketCap":4717305},{"date":"2022-12-16","current":-0.381045,"twenty":-1.083947,"median":-0.59593,"eighty":-0.361028,"marketCap":3607351},{"date":"2022-12-23","current":-0.311024,"twenty":-1.067795,"median":-0.594423,"eighty":-0.354976,"marketCap":2944461},{"date":"2022-12-30","current":-0.846766,"twenty":-1.054193,"median":-0.590172,"eighty":-0.352489,"marketCap":8016335},{"date":"2023-01-06","current":-0.785441,"twenty":-1.058443,"median":-0.595109,"eighty":-0.354169,"marketCap":7435768},{"date":"2023-01-13","current":-1.118311,"twenty":-1.058443,"median":-0.597622,"eighty":-0.356394,"marketCap":10587051},{"date":"2023-01-20","current":-0.996847,"twenty":-1.067829,"median":-0.602301,"eighty":-0.358201,"marketCap":9437147},{"date":"2023-01-27","current":-0.938209,"twenty":-1.066328,"median":-0.605735,"eighty":-0.359453,"marketCap":8882021},{"date":"2023-02-03","current":-1.143442,"twenty":-1.078731,"median":-0.610649,"eighty":-0.360164,"marketCap":10824963},{"date":"2023-02-10","current":-0.967528,"twenty":-1.070566,"median":-0.618682,"eighty":-0.361739,"marketCap":9159584},{"date":"2023-02-17","current":-0.967528,"twenty":-1.067829,"median":-0.630252,"eighty":-0.363512,"marketCap":9159584},{"date":"2023-02-24","current":-0.904701,"twenty":-1.066945,"median":-0.631818,"eighty":-0.363839,"marketCap":8564806},{"date":"2023-03-03","current":-0.900513,"twenty":-1.063862,"median":-0.637102,"eighty":-0.363839,"marketCap":8525154},{"date":"2023-03-10","current":-0.846063,"twenty":-1.045691,"median":-0.641867,"eighty":-0.365524,"marketCap":8009679},{"date":"2023-03-17","current":-0.795802,"twenty":-1.030354,"median":-0.647255,"eighty":-0.365881,"marketCap":7533857},{"date":"2023-03-24","current":-0.517989,"twenty":-1.005224,"median":-0.646473,"eighty":-0.365962,"marketCap":7386522},{"date":"2023-03-31","current":-1.111781,"twenty":-1.005224,"median":-0.644425,"eighty":-0.366126,"marketCap":15853999},{"date":"2023-04-06","current":-0.688546,"twenty":-1.01025,"median":-0.647255,"eighty":-0.367236,"marketCap":9818669},{"date":"2023-04-14","current":-0.713644,"twenty":-1.001873,"median":-0.652987,"eighty":-0.368102,"marketCap":10176564},{"date":"2023-04-21","current":-0.654174,"twenty":-1.001035,"median":-0.65541,"eighty":-0.369295,"marketCap":9328517},{"date":"2023-04-28","current":-0.737945,"twenty":-1.001035,"median":-0.654615,"eighty":-0.371189,"marketCap":10523092},{"date":"2023-05-05","current":-0.628469,"twenty":-0.997685,"median":-0.65541,"eighty":-0.372642,"marketCap":8961974},{"date":"2023-05-12","current":-0.656852,"twenty":-0.995114,"median":-0.654615,"eighty":-0.373035,"marketCap":9366708},{"date":"2023-05-19","current":-0.732361,"twenty":-0.993063,"median":-0.656852,"eighty":-0.374309,"marketCap":9077612},{"date":"2023-05-25","current":-0.676384,"twenty":-0.991322,"median":-0.659918,"eighty":-0.377706,"marketCap":8383782},{"date":"2023-06-02","current":-0.778028,"twenty":-0.988731,"median":-0.663013,"eighty":-0.380276,"marketCap":9643654},{"date":"2023-06-09","current":-0.869878,"twenty":-0.98448,"median":-0.667097,"eighty":-0.382166,"marketCap":10782141},{"date":"2023-06-15","current":-0.875281,"twenty":-0.981929,"median":-0.67307,"eighty":-0.384204,"marketCap":10849110},{"date":"2023-06-23","current":-0.923908,"twenty":-0.981929,"median":-0.674471,"eighty":-0.385274,"marketCap":11451839},{"date":"2023-06-30","current":-0.864475,"twenty":-0.980827,"median":-0.677186,"eighty":-0.386075,"marketCap":10715171},{"date":"2023-07-07","current":-0.950923,"twenty":-0.97876,"median":-0.681631,"eighty":-0.386553,"marketCap":11786688},{"date":"2023-07-14","current":-1.102206,"twenty":-0.981929,"median":-0.685714,"eighty":-0.387278,"marketCap":13661843},{"date":"2023-07-21","current":-1.085997,"twenty":-0.98788,"median":-0.687352,"eighty":-0.387446,"marketCap":13460933},{"date":"2023-07-28","current":-1.167042,"twenty":-0.998522,"median":-0.69044,"eighty":-0.387685,"marketCap":14465481},{"date":"2023-08-04","current":-1.123818,"twenty":-1.015276,"median":-0.695051,"eighty":-0.389582,"marketCap":13929722},{"date":"2023-08-11","current":-0.372805,"twenty":-1.046685,"median":-0.69506,"eighty":-0.389582,"marketCap":4620917},{"date":"2023-08-18","current":-0.316168,"twenty":-1.036489,"median":-0.691021,"eighty":-0.386075,"marketCap":4250561},{"date":"2023-08-25","current":-0.316168,"twenty":-1.015276,"median":-0.688546,"eighty":-0.377706,"marketCap":4250561},{"date":"2023-09-01","current":-0.347683,"twenty":-1.002711,"median":-0.685385,"eighty":-0.372322,"marketCap":4674246},{"date":"2023-09-08","current":-0.397658,"twenty":-1.001035,"median":-0.683343,"eighty":-0.370372,"marketCap":5346109},{"date":"2023-09-15","current":-0.424944,"twenty":-1.001035,"median":-0.677186,"eighty":-0.371839,"marketCap":5712941},{"date":"2023-09-19","current":-0.414479,"twenty":-1.001035,"median":-0.676384,"eighty":-0.37208,"marketCap":5572256},{"date":"2023-09-29","current":-0.368654,"twenty":-1.001035,"median":-0.674471,"eighty":-0.368654,"marketCap":4956181},{"date":"2023-10-06","current":-0.39054,"twenty":-0.996847,"median":-0.66982,"eighty":-0.369556,"marketCap":5250426},{"date":"2023-10-13","current":-0.378092,"twenty":-0.995114,"median":-0.666828,"eighty":-0.371189,"marketCap":5083074},{"date":"2023-10-17","current":-0.411059,"twenty":-0.994276,"median":-0.664374,"eighty":-0.371839,"marketCap":5526280},{"date":"2023-11-02","current":-0.376177,"twenty":-0.993063,"median":-0.66128,"eighty":-0.372563,"marketCap":5057328},{"date":"2023-11-10","current":-0.355659,"twenty":-0.990876,"median":-0.656852,"eighty":-0.371023,"marketCap":4781473},{"date":"2023-11-17","current":-0.36942,"twenty":-0.98703,"median":-0.65541,"eighty":-0.369529,"marketCap":4820558},{"date":"2023-11-24","current":-0.413213,"twenty":-0.98448,"median":-0.654174,"eighty":-0.370164,"marketCap":5392020},{"date":"2023-12-01","current":-0.441467,"twenty":-0.981929,"median":-0.652797,"eighty":-0.371138,"marketCap":5760705},{"date":"2023-12-08","current":-0.431578,"twenty":-0.981562,"median":-0.649739,"eighty":-0.371431,"marketCap":5631665},{"date":"2023-12-15","current":-0.416816,"twenty":-0.97876,"median":-0.646473,"eighty":-0.371839,"marketCap":5439027},{"date":"2023-12-22","current":-0.420347,"twenty":-0.973249,"median":-0.644586,"eighty":-0.372825,"marketCap":5485113},{"date":"2023-12-29","current":-0.461881,"twenty":-0.972713,"median":-0.642377,"eighty":-0.372883,"marketCap":6027080},{"date":"2024-01-05","current":-0.385997,"twenty":-0.972207,"median":-0.641518,"eighty":-0.372969,"marketCap":5036876},{"date":"2024-01-12","current":-0.376548,"twenty":-0.970041,"median":-0.637102,"eighty":-0.373217,"marketCap":4913573},{"date":"2024-01-19","current":-0.376548,"twenty":-0.967528,"median":-0.633446,"eighty":-0.373143,"marketCap":4913573},{"date":"2024-01-26","current":-0.363049,"twenty":-0.96669,"median":-0.630286,"eighty":-0.372825,"marketCap":4737426},{"date":"2024-02-02","current":-0.416981,"twenty":-0.962806,"median":-0.628469,"eighty":-0.372825,"marketCap":5441185},{"date":"2024-02-09","current":-0.319738,"twenty":-0.96037,"median":-0.623231,"eighty":-0.371427,"marketCap":4172255},{"date":"2024-02-16","current":-0.314051,"twenty":-0.957505,"median":-0.61381,"eighty":-0.369425,"marketCap":4098049},{"date":"2024-02-23","current":-0.300332,"twenty":-0.950923,"median":-0.60922,"eighty":-0.368249,"marketCap":3919026},{"date":"2024-03-01","current":-0.285759,"twenty":-0.94552,"median":-0.603229,"eighty":-0.365962,"marketCap":3728872},{"date":"2024-03-08","current":-0.278224,"twenty":-0.942397,"median":-0.599359,"eighty":-0.363839,"marketCap":3630548},{"date":"2024-03-15","current":-0.261235,"twenty":-0.940117,"median":-0.595519,"eighty":-0.363404,"marketCap":3408857},{"date":"2024-03-22","current":-0.277087,"twenty":-0.938209,"median":-0.593738,"eighty":-0.36253,"marketCap":3615707},{"date":"2024-03-28","current":-0.410438,"twenty":-0.938209,"median":-0.582356,"eighty":-0.361028,"marketCap":5048382},{"date":"2024-04-05","current":-0.398186,"twenty":-0.938209,"median":-0.571746,"eighty":-0.361914,"marketCap":4897684},{"date":"2024-04-12","current":-0.303182,"twenty":-0.931507,"median":-0.565353,"eighty":-0.361028,"marketCap":3729136},{"date":"2024-04-19","current":-0.350943,"twenty":-0.929832,"median":-0.559354,"eighty":-0.359061,"marketCap":4316603},{"date":"2024-04-26","current":-0.431238,"twenty":-0.929832,"median":-0.552601,"eighty":-0.357464,"marketCap":5304228},{"date":"2024-05-03","current":-0.504611,"twenty":-0.929832,"median":-0.549758,"eighty":-0.359061,"marketCap":6206713},{"date":"2024-05-10","current":-0.480384,"twenty":-0.929415,"median":-0.546835,"eighty":-0.35977,"marketCap":5908722},{"date":"2024-05-17","current":-0.407804,"twenty":-0.929311,"median":-0.543164,"eighty":-0.361028,"marketCap":5500050},{"date":"2024-05-24","current":-0.358259,"twenty":-0.924989,"median":-0.534344,"eighty":-0.35977,"marketCap":4831834},{"date":"2024-05-31","current":-0.320072,"twenty":-0.923908,"median":-0.527464,"eighty":-0.358121,"marketCap":4316813},{"date":"2024-06-07","current":-0.325627,"twenty":-0.918102,"median":-0.520417,"eighty":-0.352702,"marketCap":4391725},{"date":"2024-06-14","current":-0.315212,"twenty":-0.913389,"median":-0.514587,"eighty":-0.349811,"marketCap":4251265},{"date":"2024-06-21","current":-0.330487,"twenty":-0.911478,"median":-0.507968,"eighty":-0.342356,"marketCap":4457273},{"date":"2024-06-28","current":-0.317295,"twenty":-0.910184,"median":-0.505842,"eighty":-0.339575,"marketCap":4279357},{"date":"2024-07-05","current":-0.30202,"twenty":-0.907214,"median":-0.504098,"eighty":-0.335275,"marketCap":4073348},{"date":"2024-07-12","current":-0.31174,"twenty":-0.904701,"median":-0.501591,"eighty":-0.330597,"marketCap":4204444},{"date":"2024-07-15","current":-0.315212,"twenty":-0.904701,"median":-0.49994,"eighty":-0.330487,"marketCap":4251265},{"date":"2024-08-02","current":-0.253419,"twenty":-0.904701,"median":-0.498289,"eighty":-0.329742,"marketCap":3417867},{"date":"2024-08-09","current":-0.252725,"twenty":-0.902443,"median":-0.487711,"eighty":-0.32575,"marketCap":3408503},{"date":"2024-08-16","current":-0.310036,"twenty":-0.900786,"median":-0.476087,"eighty":-0.322579,"marketCap":4394446},{"date":"2024-08-23","current":-0.300008,"twenty":-0.900513,"median":-0.47231,"eighty":-0.321132,"marketCap":4252308},{"date":"2024-08-30","current":-0.300843,"twenty":-0.897617,"median":-0.467585,"eighty":-0.319624,"marketCap":4264153},{"date":"2024-09-06","current":-0.306693,"twenty":-0.894355,"median":-0.465907,"eighty":-0.318303,"marketCap":4347067},{"date":"2024-09-13","current":-0.311707,"twenty":-0.892632,"median":-0.462608,"eighty":-0.317049,"marketCap":4418136},{"date":"2024-09-20","current":-0.320064,"twenty":-0.892326,"median":-0.459208,"eighty":-0.317065,"marketCap":4536585},{"date":"2024-09-27","current":-0.281623,"twenty":-0.890568,"median":-0.455058,"eighty":-0.316168,"marketCap":3991721},{"date":"2024-10-04","current":-0.297501,"twenty":-0.888577,"median":-0.448457,"eighty":-0.315212,"marketCap":4216773},{"date":"2024-10-11","current":-0.290815,"twenty":-0.887947,"median":-0.444099,"eighty":-0.313361,"marketCap":4122014},{"date":"2024-10-18","current":-0.298336,"twenty":-0.885675,"median":-0.442122,"eighty":-0.312157,"marketCap":4228618},{"date":"2024-10-25","current":-0.289144,"twenty":-0.881819,"median":-0.442081,"eighty":-0.31174,"marketCap":4098325},{"date":"2024-10-31","current":-0.259059,"twenty":-0.880257,"median":-0.44122,"eighty":-0.311068,"marketCap":3671909},{"date":"2024-11-08","current":-0.212262,"twenty":-0.878267,"median":-0.439544,"eighty":-0.310352,"marketCap":3008596},{"date":"2024-11-15","current":-0.220644,"twenty":-0.87312,"median":-0.438648,"eighty":-0.309383,"marketCap":3103355},{"date":"2024-11-22","current":-0.230645,"twenty":-0.869878,"median":-0.434565,"eighty":-0.307597,"marketCap":3244019},{"date":"2024-11-29","current":-0.232535,"twenty":-0.868865,"median":-0.433153,"eighty":-0.30673,"marketCap":3270609},{"date":"2024-12-06","current":-0.165421,"twenty":-0.864746,"median":-0.431408,"eighty":-0.304339,"marketCap":2326653},{"date":"2024-12-13","current":-0.223083,"twenty":-0.864475,"median":-0.429318,"eighty":-0.30202,"marketCap":3137657},{"date":"2024-12-20","current":-0.170148,"twenty":-0.864475,"median":-0.427619,"eighty":-0.300848,"marketCap":2393128},{"date":"2024-12-27","current":-0.167312,"twenty":-0.864475,"median":-0.427376,"eighty":-0.300008,"marketCap":2353243},{"date":"2025-01-03","current":-0.175819,"twenty":-0.862276,"median":-0.425615,"eighty":-0.298713,"marketCap":2472899},{"date":"2025-01-10","current":-0.189998,"twenty":-0.858019,"median":-0.424813,"eighty":-0.297501,"marketCap":2672327},{"date":"2025-01-17","current":-0.156914,"twenty":-0.853695,"median":-0.424683,"eighty":-0.296397,"marketCap":2206996},{"date":"2025-01-24","current":-0.139899,"twenty":-0.851577,"median":-0.423458,"eighty":-0.29497,"marketCap":1967683},{"date":"2025-01-31","current":-0.281219,"twenty":-0.850213,"median":-0.422628,"eighty":-0.294391,"marketCap":3955351},{"date":"2025-02-07","current":-0.255654,"twenty":-0.850155,"median":-0.421689,"eighty":-0.291697,"marketCap":3595774},{"date":"2025-02-14","current":-0.202557,"twenty":-0.849841,"median":-0.420673,"eighty":-0.288648,"marketCap":2848959},{"date":"2025-02-21","current":-0.192724,"twenty":-0.849371,"median":-0.420347,"eighty":-0.287568,"marketCap":2710660},{"date":"2025-02-28","current":-0.162045,"twenty":-0.849371,"median":-0.418149,"eighty":-0.286746,"marketCap":2279167},{"date":"2025-03-07","current":-0.164602,"twenty":-0.849371,"median":-0.417423,"eighty":-0.2853,"marketCap":2315125},{"date":"2025-03-14","current":-0.180433,"twenty":-0.84915,"median":-0.416981,"eighty":-0.283159,"marketCap":2537786},{"date":"2025-03-21","current":-0.154081,"twenty":-0.847966,"median":-0.416696,"eighty":-0.281643,"marketCap":2167145},{"date":"2025-03-28","current":-0.209966,"twenty":-0.846669,"median":-0.415332,"eighty":-0.281219,"marketCap":3031487},{"date":"2025-04-04","current":-0.19611,"twenty":-0.846239,"median":-0.413798,"eighty":-0.278423,"marketCap":2831440},{"date":"2025-04-11","current":-0.207073,"twenty":-0.846031,"median":-0.412841,"eighty":-0.273332,"marketCap":2989719},{"date":"2025-04-17","current":-0.213255,"twenty":-0.845904,"median":-0.412325,"eighty":-0.26877,"marketCap":3078975},{"date":"2025-04-25","current":-0.223974,"twenty":-0.843194,"median":-0.411077,"eighty":-0.265745,"marketCap":3233733},{"date":"2025-05-02","current":-0.237708,"twenty":-0.842863,"median":-0.410438,"eighty":-0.261235,"marketCap":3432021},{"date":"2025-05-09","current":-0.232927,"twenty":-0.841653,"median":-0.409293,"eighty":-0.256637,"marketCap":3362994},{"date":"2025-05-16","current":-0.227545,"twenty":-0.837686,"median":-0.408074,"eighty":-0.254212,"marketCap":2990163},{"date":"2025-05-23","current":-0.253106,"twenty":-0.837017,"median":-0.406762,"eighty":-0.253106,"marketCap":3326062},{"date":"2025-05-30","current":-0.229953,"twenty":-0.836999,"median":-0.405958,"eighty":-0.25303,"marketCap":3021814},{"date":"2025-06-06","current":-0.248267,"twenty":-0.834541,"median":-0.404031,"eighty":-0.25303,"marketCap":3262477},{"date":"2025-06-13","current":-0.251807,"twenty":-0.833584,"median":-0.403377,"eighty":-0.251713,"marketCap":3308995},{"date":"2025-06-20","current":-0.233743,"twenty":-0.832633,"median":-0.402244,"eighty":-0.248442,"marketCap":3071611},{"date":"2025-06-27","current":-0.260493,"twenty":-0.831326,"median":-0.40021,"eighty":-0.248442,"marketCap":3423132},{"date":"2025-07-03","current":-0.26458,"twenty":-0.830227,"median":-0.398957,"eighty":-0.248384,"marketCap":3476843},{"date":"2025-07-11","current":-0.284651,"twenty":-0.828686,"median":-0.398125,"eighty":-0.249392,"marketCap":3740603},{"date":"2025-07-18","current":-0.272243,"twenty":-0.826515,"median":-0.397044,"eighty":-0.25092,"marketCap":3577551},{"date":"2025-07-24","current":-0.445224,"twenty":-0.8231,"median":-0.396172,"eighty":-0.25143,"marketCap":5850688}],"updateTime":1753483627199}}}